暴发性艰难梭菌结肠炎:转流性回肠造口与全结肠切除术的趋势
该回顾性队列研究利用美国全国住院患者样本数据库2011年1月至2015年9月数据,纳入3021例因艰难梭菌结肠炎手术的成人患者,其中2408例接受次全结肠切除术、613例接受转流性回肠造口。转流性回肠造口比例从2011年11.16%升至2015年25.30%,两组院内死亡率无显著差异(25.98% vs 31.18%;P=0.28)。
要点
- 转流性回肠造口治疗艰难梭菌结肠炎的比例逐年上升。
- 回肠造口组与结肠切除组院内死亡率无显著差异。
- 回肠造口更多在入院首日实施(23.31% vs 12.21%)。
核心结论
- 转流性回肠造口在美国逐渐被用于治疗艰难梭菌结肠炎。
- 暴发性艰难梭菌结肠炎死亡率仍高,但回肠造口与全结肠切除术的院内死亡率无显著差异。
- 回肠造口可能是全结肠切除术的一种可行手术替代方案。
研究设计与样本
- 回顾性队列研究,使用美国全国住院患者样本数据库2011年1月至2015年9月数据。
- 纳入3021例因艰难梭菌结肠炎手术的成人患者,其中次全结肠切除术2408例、转流性回肠造口613例。
主要发现
- 研究期间613例(20.28%)接受转流性回肠造口而未行全结肠切除术。
- 仅行转流术的年度比例从2011年11.16%上升至2015年25.30%。
- 回肠造口在入院首日实施的比例显著高于次全结肠切除术(23.31% vs 12.21%;P < .01)。
- 两组院内死亡率分别为25.98%与31.18%,差异无统计学意义(P = .28)。
临床怎么用
- 对于暴发性艰难梭菌结肠炎,转流性回肠造口可作为全结肠切除术的潜在替代术式。
- 需进一步明确选择转流性回肠造口而非全结肠切除术的适应证标准。
局限性
- 回顾性研究设计可能受选择偏倚影响。
- 研究未阐明选择转流性回肠造口或全结肠切除术的具体依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Diverting loop ileostomy and colonic lavage has generated much interest since it was first reported as a potential alternative to total abdominal colectomy for treating Clostridium difficile colitis in 2011. To our knowledge, few studies have validated the benefit reported in the initial description, and the association of this new approach with practice patterns has not been described. OBJECTIVE: To examine the national adoption pattern and outcomes of diverting loop ileostomy vs total abdominal colectomy as treatment for fulminant C difficile colitis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from hospitals participating in the National Inpatient Sample database across the United States from January 2011 to September 2015 and included 3021 adult patients who underwent surgery for C difficile colitis during the study period, comprising 2408 subtotal colectomies and 613 loop ileostomies. The data were analyzed between November 2018 and April 2019. EXPOSURES: Loop ileostomy as surgery of choice. MAIN OUTCOMES AND MEASURES: In-hospital mortality. RESULTS: Of 2408 participants, 1416 (58.8%) were women, 1781 (78.4%) were white, and 627 (21.6%) were individuals of color and the mean (SD) age was 68.2 (14.8) years. During the overall study period, 613 patients (20.28%) underwent diverting loop ileostomy without total abdominal colectomy. The annual proportion of patients undergoing only diversion increased from 11.16% in 2011 to 25.30% in 2015. Significantly more loop ileostomies were performed within the first day of hospitalization, in contrast to subtotal colectomies (23.31% vs 12.21%; P < .01). There was no significant difference in in-hospital mortality rates between the 2 groups (25.98% vs 31.18%; P = .28). CONCLUSIONS AND RELEVANCE: This study demonstrates the adoption of diverting loop ileostomy to treat C difficile colitis across the United States. While fulminant C difficile colitis remains a condition with high mortality rates, no significant difference in this outcome was observed between loop ileostomy and total abdominal colectomy. Loop ileostomy may represent a viable surgical alternative to total abdominal colectomy, although the grounds for selection of treatment need to be clarified.
引用
- Juo YY, Sanaiha Y, Jabaji Z, et al. Trends in Diverting Loop Ileostomy vs Total Abdominal Colectomy as Surgical Management for Clostridium difficile Colitis. JAMA Surg. 2019. PMID: 31268492. doi:10.1001/jamasurg.2019.2141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。